TYW2 and colonic neoplasm: Using a Transwell assay, we found that CRISPR/cas9-mediated deletion of TYW2 in the unmethylated and expressing HCT-116 and SW480 colon cancer cell lines induced a significant increase in the migration potential of the obtained TYW2-deficient cells (Fig. 4C).